Related Experiment Video
Updated: May 4, 2026
10:25
Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System
Published on: September 20, 2019
6.9K
Research progress in OX40/OX40L in allergic diseases.
Rongrong Song1, Huanlei Zhang1, Zhuoping Liang1
1Department of Otolaryngology Head and Neck Surgery, The Affiliated Hospital of Southwest Medical University, Sichuan, China.
International Forum of Allergy & Rhinology
|October 15, 2024
Summary
The OX40/OX40L pathway is crucial for T cell regulation in allergic diseases. Targeting this pathway shows promise for new T-cell-mediated disease treatments.
Area of Science:
- Immunology
- Allergy Research
- Molecular Biology
Background:
- OX40/OX40L are costimulatory molecules within the tumor necrosis factor superfamily.
- These molecules are integral to immune regulation, influencing T cell proliferation, differentiation, and memory formation.
Purpose of the Study:
- To review the significant role of OX40/OX40L in the pathogenesis of allergic diseases.
- To summarize recent advancements in therapeutic strategies targeting the OX40/OX40L signaling pathway for T-cell-mediated conditions.
Main Methods:
- Literature review of existing studies on OX40/OX40L.
- Analysis of clinical trial data for OX40/OX40L-targeted therapies.
- Synthesis of current understanding of OX40/OX40L in allergic disease mechanisms.
Main Results:
- The OX40/OX40L pathway critically impacts T cell responses relevant to allergies.
- Emerging therapies targeting OX40/OX40L demonstrate potential for managing T-cell-mediated allergic diseases.
Conclusions:
- The OX40/OX40L pathway represents a key target for developing novel treatments for allergic diseases.
- Further research and clinical investigation into OX40/OX40L modulation are warranted for therapeutic benefit.
